Physician profile
Joseph Parkhurst
NPI 1205879772
$1,642.55
in general payments reported to CMS, 2019-2025
19 companies · $18.78 in 2025
The $18.78 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $517 · 2021: $162 · 2022: $36.12 · 2023: $16.36 · 2024: $24.84 · 2025: $18.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $296.89 | 2019-2024 | |
| Clarus Therapeutics INC. | $190.33 | 2020-2021 | |
| Pfizer INC. | $168.82 | 2019-2020 | |
| Astellas Pharma US INC | $167.61 | 2019-2021 | |
| Allergan, INC. | $136.70 | 2019 | |
| Boston Scientific Corporation | $135.06 | 2019 | |
| Amag Pharmaceuticals, INC. | $115.31 | 2019 | |
| Janssen Biotech, INC. | $111.75 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $78.39 | 2019 | |
| Neotract INC. | $50.38 | 2019-2020 | |
| Antares Pharma, INC. | $46.36 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $24.11 | 2019-2020 | |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Ethicon US, LLC | $18.78 | 2025 | Vistaseal |
| Medtronic USA, INC. | $17.62 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.37 | 2019 | |
| Axonics, INC. | $16.36 | 2023 | Axonics |
| Therapeuticsmd, INC. | $16.21 | 2019 | |
| Zyla Life Sciences, INC. | $11.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Parkhurst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.